Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-coagulation Therapy”

271 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 271 results

Not applicableStudy completedNCT04412980
What this trial is testing

Ionized Magnesium for Monitoring of Citrate-anticoagulated CVVHD

Who this might be right for
Intensive Care Unit Syndrome
University Hospital, Montpellier 40
Testing effectiveness (Phase 2)Study completedNCT01997905
What this trial is testing

Stroke Feasibility Study

Who this might be right for
Atrial FibrillationAFib
AtriCure, Inc. 13
Not applicableNot Yet RecruitingNCT06869083
What this trial is testing

Application-Delivered Patient Education in Enhancing the Usage of Apixaban in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation on Apixaban Treatment
Yonsei University 5,200
Post-approval studies (Phase 4)Study completedNCT02247128
What this trial is testing

Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation

Who this might be right for
Aortic Valve DiseaseMyocardial InfarctionStroke+1 more
St. Antonius Hospital 1,016
Not applicableNot Yet RecruitingNCT06866665
What this trial is testing

Antithrombotic Strategy for AF Patients With High Risk CAD

Who this might be right for
Atrial FibrillationCoronary Artery Disease
Yonsei University 1,400
Testing effectiveness (Phase 2)UnknownNCT05602129
What this trial is testing

A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects

Who this might be right for
Renal Replacement Therapy
Haisco Pharmaceutical Group Co., Ltd. 156
Not applicableWithdrawnNCT01810237
What this trial is testing

Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy

Who this might be right for
Venous Thromboses
Nova Scotia Health Authority
Testing effectiveness (Phase 2)Looking for participantsNCT07234019
What this trial is testing

Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 160
Not applicableTemporarily pausedNCT01305148
What this trial is testing

Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)

Who this might be right for
Anti-coagulation TherapyDVTPulmonary Embolism+3 more
Iverson Genetic Diagnostics, Inc. 3,800
Large-scale testing (Phase 3)Not Yet RecruitingNCT07746882
What this trial is testing

Study on Anti-Thrombotic Regimens for Secondary Prevention in Ischemic Stroke Patients With Possible Benefit From Anticoagulation Therapy

Who this might be right for
StrokeAcute Ischemic Stroke
Second Affiliated Hospital, Zhejiang University, School of Medicine 680
Not applicableStudy completedNCT03182829
What this trial is testing

In Vitro Diagnostic Test for DOAC in Urine

Who this might be right for
Anticoagulant Therapy
Doasense GmbH 880
Not applicableStudy completedNCT01036646
What this trial is testing

User Performance Evaluation of the INRatio® Prothrombin Time (PT) Monitoring System With a New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity

Who this might be right for
Oral Anticoagulation
Abbott RDx Cardiometabolic 183
Testing effectiveness (Phase 2)Looking for participantsNCT05995054
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 110
Post-approval studies (Phase 4)Active Not RecruitingNCT07185295
What this trial is testing

Short-term Interruption Versus Continuous Anticoagulation in Colorectal Polypectomy

Who this might be right for
Anticoagulated Patients
Outcomes'10 481
Not applicableStudy completedNCT01559883
What this trial is testing

Study on Thrombosis Therapy in German Cancer Patients

Who this might be right for
CancerDeep Vein ThrombosisPulmonary Embolism
LEO Pharma 76
Not applicableStudy completedNCT03280641
What this trial is testing

D-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation Therapy

Who this might be right for
Atrial FibrillationStrokes Thrombotic
Wuhan Asia Heart Hospital 1,194
Not applicableUnknownNCT03573037
What this trial is testing

Anticoagulation After RFCA

Who this might be right for
Atrial Fibrillation
Yong Seog Oh 246
Large-scale testing (Phase 3)Study completedNCT05814341
What this trial is testing

Citrate Anticoagulation in Renal Replacement Therapy: Impact of a High Post-filter Calcium Target on Efficacy

Who this might be right for
Renal Replacement Therapy
Assistance Publique - Hôpitaux de Paris 108
Early research (Phase 1)Study completedNCT00055159
What this trial is testing

Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins

Who this might be right for
Thrombosis
National Institutes of Health Clinical Center (CC) 50
Large-scale testing (Phase 3)UnknownNCT00432796
What this trial is testing

PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.

Who this might be right for
Stroke
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 1,473
Next Page